The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...
Prescription claims data were searched to identify the first claim for raloxifene or a bisphosphonate between January 2003 and December 2004 for patients. In the commercial/Medicare data 102,750 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results